Enhanced Recovery Protocol After Cesarean Section (ERAC)
Effectiveness of Implementing Enhanced Recovery After Cesarean Section Protocol on Maternal and Neonatal Outcomes
This study aims to evaluate the effectiveness of implementing the Enhanced Recovery After Cesarean (ERAC) protocol on maternal and neonatal outcomes.
Research hypotheses
To fulfill the aim of the study, the following research hypotheses are formulated:
Hypothesis I: Women who receive the ERAC protocol experience faster recovery compared to those who receive routine hospital nursing care.
Hypothesis II: Women who receive the ERAC protocol experience fewer maternal and neonatal complications than those who receive routine hospital nursing care.
研究概览
详细说明
Cesarean section (CS) remains one of the most common surgical procedures in obstetric practice. Worldwide CS rates have become an important public health concern because of their implications for maternal and neonatal healthcare. In many countries, including Egypt, cesarean delivery rates have increased substantially during recent decades, often exceeding recommended levels.
Cesarean section is a lifesaving procedure when medically indicated. Common indications include fetal malpresentation, multiple pregnancy, chorioamnionitis, arrested labor, oligohydramnios, umbilical cord prolapse, cephalopelvic disproportion, eclampsia, and hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome. Elective CS may also be influenced by fear of vaginal birth and concerns regarding labor-related complications, including pelvic organ prolapse and perineal injury.
Although CS is generally considered safe, it remains associated with several intraoperative and postoperative maternal and neonatal risks. Intraoperative maternal complications include hypotension, local anesthetic toxicity, post-dural puncture headache, nerve injury, endometritis, severe bleeding, and urinary tract or bowel injury. Postoperative complications include abdominal pain, bowel obstruction, incisional hernia, pelvic adhesions, postpartum hemorrhage, deep vein thrombosis, increased risks of placenta previa or placental abruption in subsequent pregnancies, prolonged hospitalization, delayed functional recovery, emotional distress, delayed maternal-infant bonding, and reduced patient satisfaction.
Neonatal risks associated with CS include birth injury, persistent tachypnea, respiratory distress syndrome, transient tachypnea of the newborn, low birth weight, low Apgar scores, and admission to the neonatal intensive care unit (NICU). Such complications occur more frequently after emergency CS than after elective CS or vaginal birth.
The increasing global rate of CS highlights the need to improve the quality of perioperative care provided to women undergoing cesarean delivery. Evidence-based practices emphasizing patient education, informed consent, and shared decision-making contribute to safer and more individualized maternity care. The Enhanced Recovery After Cesarean (ERAC) protocol standardizes preoperative, intraoperative, and postoperative care to improve recovery and quality of care.
The ERAC protocol includes a comprehensive set of evidence-based interventions designed to enhance maternal recovery and reduce maternal and neonatal complications. The pathway extends from the decision for cesarean delivery until hospital discharge. Preoperative care includes patient education, reduced preoperative fasting, maintenance of normothermia, and optimization of hemoglobin levels. Intraoperative care includes prophylactic antibiotics, appropriate fluid preload or co-load, phenylephrine infusion, neuraxial anesthesia with opioid-sparing analgesia, delayed cord clamping, skin-to-skin contact, and early initiation of breastfeeding.
Postoperative ERAC care includes prophylaxis for postoperative nausea and vomiting (PONV), multimodal analgesia, early oral intake, early ambulation, early urinary catheter removal, lactation support, and streamlined hospital discharge. The ERAC protocol provides an evidence-based approach to reducing surgical complications, improving maternal outcomes and functional recovery, strengthening maternal-infant bonding, enhancing patient experience, and shortening hospital length of stay.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Dakhalia
-
Al Mansurah、Dakhalia、埃及、34511
- Mansoura University Hospital
-
-
参与标准
资格标准
适合学习的年龄
- 成人
接受健康志愿者
描述
Inclusion Criteria:
- Women undergoing planned cesarean delivery.
- Scheduled to receive neuraxial anesthesia.
- Gestational age of 37 weeks or more.
- Singleton pregnancy.
Exclusion Criteria:
- Women requiring additional interventions outside the Enhanced Recovery After Cesarean (ERAC) pathway, including severe coagulopathy or active infection.
- Women expected to require prolonged hospitalization because of a history of uterine rupture, pre-existing hypertension, pregnancy-induced hypertension, or placenta accreta.
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Experimental :ERAC arm (intervention)
The intervention group will receive the Enhanced Recovery After Cesarean (ERAC) protocol of care, consisting of the following components: Preoperative care:
Intraoperative care:
Postoperative care: • Prophylaxis for pos |
• The intervention group will receive the Enhanced Recovery after Cesarean protocol of Care which consists of: Preoperative Care:
Intraoperative Care:
|
|
有源比较器:Routine care arm
The control group will receive routine nursing care only (pre-operative, intraoperative and postoperative).NPO for at least 8 hrs for food and fluid ,immediate cord clamping ,no mutlimodal analgesia ,catheter removal after at least 12 hrs
|
The control group will receive routine preoperative, intraoperative, and postoperative nursing care according to standard hospital practice. Preoperative care: • Fasting from both food and fluids for at least 8 hours before surgery. Intraoperative care: • Immediate umbilical cord clamping after birth. Postoperative care:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Maternal quality of recovery score
大体时间:at day 0 and 2 weeks postoperative
|
Maternal quality of recovery will be measured using a 40-item questionnaire.
Each item is rated on a three-point Likert scale: 1 = rarely, 2 = sometimes, and 3 = always.
Scores are reversed for negatively worded items.
Total scores range from 40 to 120, with higher scores indicating better quality of recovery and lower scores indicating poorer quality of recovery.
|
at day 0 and 2 weeks postoperative
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Incidence of intraoperative hypotension
大体时间:day 0 of surgery
|
Occurrence of maternal hypotension during cesarean delivery, recorded as present or absent and reported as the number and percentage of women in each study group.
|
day 0 of surgery
|
|
Incidence of intraoperative nausea and vomiting
大体时间:During cesarean delivery.
|
Occurrence of maternal nausea and/or vomiting during cesarean delivery, recorded as present or absent and reported as the number and percentage of women in each study group.
|
During cesarean delivery.
|
|
Time to first semisolid food intake
大体时间:From completion of surgery until first semisolid food intake during hospitalization.
|
Time in hours from completion of cesarean delivery to the first intake of semisolid food.
|
From completion of surgery until first semisolid food intake during hospitalization.
|
|
Time to first ambulation
大体时间:From completion of surgery until first ambulation during hospitalization.
|
Time in hours from completion of cesarean delivery until the first postoperative ambulation.
|
From completion of surgery until first ambulation during hospitalization.
|
|
Hospital length of stay
大体时间:From completion of surgery until hospital discharge.
|
Duration of hospitalization measured in hours from completion of cesarean delivery until hospital discharge.
|
From completion of surgery until hospital discharge.
|
|
Hospital readmission
大体时间:Within 30 days after surgery.
|
Occurrence of hospital readmission due to maternal postoperative complications, recorded as present or absent and reported as the number and percentage of women in each study group.
|
Within 30 days after surgery.
|
|
Neonatal Outcome Measures
大体时间:At 1st and 5th minute after birth.
|
Neonatal condition measured using the Apgar score at 1 minute after birth.
The total score ranges from 0 to 10 and will be categorized as reassuring (7-10), moderately abnormal (4-6), or low (0-3), with higher scores indicating better neonatal conditio
|
At 1st and 5th minute after birth.
|
|
Neonatal intensive care unit admission
大体时间:From birth until hospital discharge.
|
Admission of the newborn to the neonatal intensive care unit, recorded as present or absent and reported as the number and percentage of newborns in each study group.
|
From birth until hospital discharge.
|
|
Neonatal birth weight
大体时间:Immediately after birth.
|
Neonatal birth weight measured in grams using a calibrated infant weighing scale immediately after birth.
|
Immediately after birth.
|
合作者和调查者
调查人员
- 首席研究员:Noura G El-Gamel, MSc、Mansoura University
- 学习椅:Enas S Fathy、Mansoura University
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- ERAC
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.